Skip to main content

Table 4 Clinical characteristics of chronic ITP patients with IL-4 and IL-4Rα

From: The cytokine polymorphisms affecting Th1/Th2 increase the susceptibility to, and severity of, chronic ITP

 

IL-4 CC

IL-4 non-CC

 

IL-4Rα QQ

IL-4Rα non-QQ

 

N

(%)

N

(%)

P value

OR

95% CI

N

(%)

N

(%)

P value

OR

95% CI

No. of patients (%)

17

(13.5)

109

(86.5)

   

88

(69.8)

38

(30.2)

   

Female patients, no. of cases (%)

16

(94.1)

76

(69.7)

0.04

6.95

0.88–54.57

65

(73.9)

27

(71.1)

0.74

1.15

0.49–2.69

Age (years) at diagnosis, range (median)

10.5–82.3

(49.1)

2.4–81.9

(47.4)

0.85

  

2.4–82.3

(46.6)

17.1–79.2

(54.9)

0.16

  

Platelet count (×109/L) at diagnosis, mean ± SD

24.5

± 22.4

30.3

± 24.7

0.36

  

29.8

± 24.8

28.9

± 23.9

0.84

  

 Mild thrombocytopenia, no. of cases (%)

3

(17.6)

25

(22.9)

0.76

0.72

0.19–2.71

18

(20.5)

10

(26.3)

0.47

0.72

0.30–1.75

 Moderate thrombocytopenia, no. of cases (%)

3

(17.6)

25

(22.9)

0.76

0.72

0.19–2.71

22

(25.0)

6

(15.8)

0.35

1.78

0.66–4.82

 Severe thrombocytopenia, no. of cases (%)

6

(35.3)

34

(31.2)

0.78

1.20

0.41–3.52

26

(29.5)

14

(36.8)

0.42

0.72

0.32–1.60

 Very severe thrombocytopenia, no. of cases (%)

5

(29.4)

25

(22.9)

0.55

1.40

0.45–4.36

22

(25.0)

8

(21.1)

0.82

1.25

0.50–3.13

Minimum platelet count (×109⁄L), mean ± SD

16.4

± 19.7

18.8

±17.8

0.61

  

17.5

± 17.4

20.8

± 19.4

0.35

  

Bleeding tendency, no. of cases (%)

11

(64.7)

69

(63.3)

1.00

1.06

0.37–3.09

55

(62.5)

25

(65.8)

0.73

0.87

0.39–1.92

  1. Mild thrombocytopenia: >50 × 109⁄L, moderate thrombocytopenia: 30 × 109–50 × 109⁄L, severe thrombocytopenia: 10 × 109–30 × 109⁄L, very severe thrombocytopenia: <10 × 109⁄L, minimum platelet count: minimum platelet count during the clinical course. ITP immune thrombocytopenia, IFN interferon, IL interleukin, OR odds ratio, CI confidence interval, SD standard deviation